UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000023248 |
|---|---|
| Receipt number | R000026708 |
| Scientific Title | Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIs |
| Date of disclosure of the study information | 2016/07/20 |
| Last modified on | 2022/07/26 16:45:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIs
Acronym
JP-CLEAR
(Japanese Prospective evaluation of tumor-derived Circulating DNA Liquid biopsy in patients with EGFR-mutant NSCLC during and after Acquired Resistance to EGFR-TKI treatment)
Scientific Title
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIs
Scientific Title:Acronym
JP-CLEAR
(Japanese Prospective evaluation of tumor-derived Circulating DNA Liquid biopsy in patients with EGFR-mutant NSCLC during and after Acquired Resistance to EGFR-TKI treatment)
Region
| Japan |
Condition
Condition
Non-small cell Lung Cancer
Classification by specialty
| Pneumology | Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To investigate the diagnostic value of plasma ctDNA of EGFR mutations in the trajectory of patients with EGFR activating mutation-positive non-small cell lung cancer(NSCLC)treated with EGFR-TKIs , including a third-generation TKI
Basic objectives2
Others
Basic objectives -Others
Diagnostic value
Trial characteristics_1
Others
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
*The plasma DNA T790M positivity rates by Cobas EGFR Mutation Test in the T790M positive tumors patients.
*The plasma DNA T790M positivity rates at each clinical point.
Key secondary outcomes
*The plasma DNA EGFR Exon 19 deletion or Exon 21 L858 mutation positivety rates in clinical courses
*Time from plasma T790 positivity to tissue T790M positivity in the tissue T790M-positive cases
*Response Rate and PFS with Osimertinib
*Response Rate and PFS with rechallenge of other EGFR-TKIs
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1)Patients diagnosed as having advanced or postoperative recurrent NSCLC prior to enrollment
2)Patients diagnosed as carrying activating EGFR mutation by each institution (exon19 deletion, exon 21 L858R mutation, or other minor mutations such as exon 18 G719X)
3)Those being treated without progression, or to be treated with, an EGFR-TKI as anticancer therapy
4)ECOG PS 0-2
5)20 years old over
6)Submitted signed informed consent
Key exclusion criteria
1)Prior treatment with EGFR-TKI
2)HBsAg or HCV-RNA positive Patients
3)HIV positive Patients
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hideo Kunitoh |
Organization
Japanese Red Cross Medical Center
Division name
Department of Medical Oncology
Zip code
Address
4-1-22 Hiroo, Shibuya-ku, Tokyo
TEL
03-3400-1311
kunito-hideo@med.jrc.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Akira Yamao |
Organization
Public Health Reseach Foundation
Division name
Comprehensive Support Project for Oncology Research
Zip code
Address
1-1-7 Nishi-waseda,Shinjuku-ku,Tokyo
TEL
03-5287-2636
Homepage URL
cspor-lc05@csp.or.jp
Sponsor or person
Institute
PHRF
Institute
Department
Personal name
Funding Source
Organization
Astra Zeneca K K
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
No
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
岩手県立中央病院（岩手県）、群馬県立がんセンター（群馬県）、国立病院機構 渋川医療センター（群馬県）、春日部市立医療センター（埼玉県）、さいたま赤十字病院（埼玉県）、杏林大学医学部付属病院（東京都）、国立研究開発法人 国立国際医療研究センター病院（東京都）、昭和大学病院（東京都）、虎の門病院（東京都）、日本赤十字社医療センター（東京都）、NTT東日本関東病院（東京都）、社会福祉法人 三井記念病院（東京都）、昭和大学藤が丘病院（神奈川県）、藤沢市民病院（神奈川県）、関西電力病院（大阪府）
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 07 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
122
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 07 | Month | 27 | Day |
Date of IRB
| 2016 | Year | 08 | Month | 05 | Day |
Anticipated trial start date
| 2016 | Year | 08 | Month | 10 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 26 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
All patients who has given consent to participate in the study during from 2016/08/01 to 2017/3/31
Management information
Registered date
| 2016 | Year | 07 | Month | 20 | Day |
Last modified on
| 2022 | Year | 07 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026708
